Modelling the Cost Effectiveness of Disease-Modifying Treatments for Multiple Sclerosis : Issues to Consider. Thompson JP, Abdolahi A, Noyes K Pharmacoeconomics. 2013 May 3. PMID: 23640103. Abstract CommentRecommendBookmarkWatch